Press & Media

Dr. Andrew Mayo Joins HaloNutraTherapy as Seed Investor as Company Announces Close of Funding Round
FOR IMMEDIATE RELEASE Physician and Mayo Clinic family member joins HNT's investor group alongside go-to-market advisor Terry Lee, as the inhalable nutraceutical platform scales ASHEVILLE, N.C. – August 6, 2026 – HaloNutraTherapy Systems, Inc. ("HNT"), maker of the patented inhalable nutraceutical platform, today announced it has closed a seed funding round from a group of investors, including Dr. Andrew Mayo and Terry Lee. The round will support manufacturing scale-up, marketing, and continued development of HNT's pipeline of inhalable wellness formulations. "We're grateful to welcome a group of investors who bring... Read more...
The Future of Supplementation: Exploring Inhalable Nutraceuticals as an Alternative Nutrient Delivery Approach
The Future of Supplementation: Exploring Inhalable Nutraceuticals as an Alternative Nutrient Delivery Approach
Many people take supplements daily, yet still wonder whether they are getting the full benefit from the products they use. One factor often discussed in nutritional science is bioavailability, or... Read more...
Carillon Miami Wellness Resort First in U.S. to Introduce HaloNutraTherapy
Carillon Miami Wellness Resort First in U.S. to Introduce HaloNutraTherapy
Carillon Miami Wellness Resort, home to one of the largest spas and wellness centers on the Eastern Seaboard, announces it is the first destination in the United States to offer... Read more...